Table 1 Demographic characteristics of the sample.

From: Increased intra-subject variability in reward behavior relates to symptom severity in schizophrenia

 

SZ (n = 90)

HC (n = 28)

Statistic

p

Age (years)

36.08 (7.59)

36.81 (7.65)

1149.50a

.48

Gender (M/F)

43/47

13/15

0.02b

.90

Education (years)

13.93 (2.79)

14.86 (2.19)

919.50a

.06

Onset

21.81 (5.33)

–

–

–

DOI (years)

14.15 (8.38)

–

–

–

CPZ (mg/day)

344.66 (253.94)

–

–

–

PANSS Marder dimensions

Positive symptom

17.30 (5.91)

–

–

–

Negative symptom

16.39 (6.39)

–

–

–

Disorganized thought

13.37 (5.59)

–

–

–

UHE

5.13 (2.00)

–

–

–

AD

6.16 (2.31)

–

–

–

PANSS scale

PANSS total

59.02 (16.51)

–

–

–

PANSS general

27.69 (8.10)

–

–

–

SANS scale

SANS total

26.66 (17.41)

–

–

–

SANS global

8.58 (5.12)

–

–

–

SANS affective

9.31 (5.72)

–

–

–

SANS alogia

4.66 (4.04)

–

–

–

SANS avolition-apathy

4.58 (3.29)

–

–

–

SANS anhedonia-asociality

5.42 (4.02)

–

–

–

SANS attention

2.69 (2.37)

–

–

–

  1. The values are presented as the mean (standard deviation).
  2. SZ patients with schizophrenia, HC healthy controls, DOI duration of illness, CPZ chlorpromazine equivalent doze, PANSS positive and negative syndrome scale, UHE uncontrolled hostility/excitement, AD anxiety/depression.
  3. aMann–Whitney U tests were used to assess between-group differences.
  4. bSex distributions were compared using the chi-squared test.